Author
A. Yisimayi
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2023 · peak 6/yrCo-Author Collaboration Network
10 top collaborators · 45 mutual co-author links13 papers
Recent·Most cited
- ImmunologybioRxiv
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
The paper shows JN.1 outcompetes BA.2.86 and other variants by evading antibodies more effectively, despite reduced ACE2 binding.
DOI 10.1016/s1473-3099(23)00744-2 - ImmunologybioRxivPreprint
Antigenicity and infectivity characterization of SARS-CoV-2 BA.2.86
S. Yang, Y. Yu, F. Jian…·Y. R. Cao
This study characterizes the antigenic properties and infectivity of the SARS-CoV-2 BA.2.86 variant, finding it evades immune responses but has reduced infectivity compared to previous variants.
DOI 10.1101/2023.09.01.555815 - ImmunologybioRxiv
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding
F. Jian, L. Feng, S. Yang…·Y. R. Cao
This study shows that convergent evolution of SARS-CoV-2 XBB lineages at RBD positions 455-456 synergistically enhances antibody evasion and ACE2 binding through epistatic interactions.
DOI 10.1371/journal.ppat.1011868 - ImmunologybioRxiv
Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
X. Chen, Y. Xu, Y. Xie…·Y. R. Cao
The paper assesses the protective effect of neutralizing antibodies from prior Omicron BA.5 infection against symptomatic reinfection with BA.5, BF.7, CH.1.1, and XBB.1.5 subvariants, finding a strong correlation between antibody titers and reduced reinfection risk.
DOI 10.1016/j.lanwpc.2023.100758 - ImmunologybioRxiv
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Y. Cao, F. Jian, J. Wang…·X. S. Xie
The paper shows that convergent evolution of Omicron variants evades antibodies from BA.5 infections while maintaining ACE2 binding, driven by immune imprinting.
DOI 10.1038/s41586-022-05644-7 - ImmunologybioRxiv
Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
F. Jian, Y. Yu, W. Song…·Y. Cao
This study shows that BA.4.6, BA.4.7, and BA.5.9 subvariants with R346 mutations evade humoral immunity more effectively than BA.4/BA.5, reducing neutralization titers by 1.5-2.6-fold.
DOI 10.1016/s1473-3099(22)00642-9 - ImmunologybioRxiv
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
Y. R. Cao, F. Jian, Z. Zhang…·X. S. Xie
The paper identifies a potent and broad sarbecovirus-neutralizing antibody cocktail, SA55+SA58, from SARS convalescents to combat Omicron variants and other fast-evolving viruses.
DOI 10.1016/j.celrep.2022.111845 - ImmunologybioRxiv
Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75
Y. Cao, W. Song, L. Wang…·X. Wang
This study characterizes the enhanced infectivity and antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75 compared to BA.5 and other variants.
DOI 10.1016/j.chom.2022.09.018 - ImmunologybioRxiv
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Y. R. Cao, A. Yisimayi, F. Jian…·X. S. Xie
This study investigates antibody evasion by SARS-CoV-2 Omicron sublineages BA.2.12.1, BA.4, and BA.5 against plasma from vaccination and BA.1 infection, showing increased neutralization escape.
DOI 10.1038/s41586-022-04980-y - ImmunologybioRxivPreprint
Omicron BA.2 specifically evades broad sarbecovirus neutralizing antibodies
Y. Cao, A. Yisimayi, F. Jian…·X. S. Xie
This study shows that BA.2 causes stronger antibody evasion than BA.1, particularly in SARS convalescents, and identifies key mutations responsible for this escape.
DOI 10.1101/2022.02.07.479349 - ImmunologybioRxiv
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Y. R. Cao, J. Wang, F. Jian…·X. S. Xie
This study identifies how Omicron evades neutralizing antibodies by analyzing mutations and their effects on different epitope groups, showing over 85% of tested antibodies are escaped.
DOI 10.1038/s41586-021-04385-3